Vera G. Calich
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
CTLA-4 blockade improves antifungal treatment outcomes in a murine model of pulmonary paracoccidioidomycosis.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: January 09, 2026
Combined anti-PD-1 and amphotericin B therapy reduces fungal burden and enhances control of murine paracoccidioidomycosis.
Journal: Frontiers in cellular and infection microbiology
Published: December 16, 2025
Specific Depletion of Myeloid-Derived Suppressor Cells by the Chemotherapy Agent 5-Fluorouracil Enhances Protective Immune Response in Paracoccidioidomycosis.
Journal: The Journal of infectious diseases
Published: March 27, 2024
MDSCs use a complex molecular network to suppress T-cell immunity in a pulmonary model of fungal infection.
Journal: Frontiers in cellular and infection microbiology
Published: February 28, 2024
Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice.
Journal: Frontiers in immunology
Published: November 30, 2023
Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection.
Journal: Frontiers in immunology
Published: August 24, 2023
Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response.
Journal: Frontiers in cellular and infection microbiology
Published: July 28, 2023
The immunosuppressive activity of myeloid-derived suppressor cells in murine Paracoccidioidomycosis relies on Indoleamine 2,3-dioxygenase activity and Dectin-1 and TLRs signaling.
Journal: Scientific reports
Published: April 28, 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
Journal: Journal of medical virology
Published: October 28, 2022
Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity.
Journal: Journal of medical virology
Published: October 13, 2022
Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy.
Journal: Frontiers in immunology
Published: September 07, 2022
Last Updated: 09/26/2026